Plasma apo/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts.

about

Metabolic syndrome among substance dependent men: A study from north India.Plasma triglyceride levels may modulate hepatitis C viral replication.

P2860

Q37491902-18DF3371-BF55-42E4-8F8C-973C67BDC9A9 Q42235591-84B3BDC6-B198-4C66-8A3A-D0694CED7590

P2860

Plasma apo/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts.

Item

http://www.wikidata.org/entity/Q43035689

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Plasma apo/lipoproteins distur ...... V seronegative heroin addicts.

@en

Plasma apo/lipoproteins distur ...... V seronegative heroin addicts.

@nl

type

Item

label

Plasma apo/lipoproteins distur ...... V seronegative heroin addicts.

@en

Plasma apo/lipoproteins distur ...... V seronegative heroin addicts.

@nl

prefLabel

Plasma apo/lipoproteins distur ...... V seronegative heroin addicts.

@en

Plasma apo/lipoproteins distur ...... V seronegative heroin addicts.

@nl

P1476

Plasma apo/lipoproteins distur ...... V seronegative heroin addicts.

@en

P2093

Andon Cibisev

http://www.w3.org/2001/XMLSchema#string

Cedomir Dimitrovski

http://www.w3.org/2001/XMLSchema#string

Cvetanka Bozinovska

http://www.w3.org/2001/XMLSchema#string

Irena Jurukov

http://www.w3.org/2001/XMLSchema#string

Lidija Petkovska

http://www.w3.org/2001/XMLSchema#string

Zanina Jovan Pereska

http://www.w3.org/2001/XMLSchema#string

P2860

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy.

Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?

Metabolic syndrome in drug abuse.

Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein.

Opium and heroin alter biochemical parameters of human's serum.

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

Safety of injectable opioid maintenance treatment for heroin dependence.

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

P304

196-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00952990.2011.563335

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21453194

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

Plasma apo/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts.

about

P2860

P2860

Plasma apo/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921